Biocon
Strong prospects of Biologics business keep Street positive on Biocon
Sebi levies fine on Biocon employee for violating insider trading norms
Biocon posts 22% fall in Q2 net profit on high R&D expenses, staff costs
India has potential to increase Covid testing 10-fold: Kiran Mazumdar-Shaw
Forbes India Rich List 2020: Ambani dominance continues; see full list

Sales of Biocon's itolizumab surge as phase-4 clinical trials begin
Biocon set for bigger insulin play, aims to reach one in five diabetics
Pick-up in biosimilar launches driving Biocon's prospects; stock rises 7.8%
Biocon shares up 6% after Co launches insulin glargine in US market
Biocon-Mylan launch insulin Glargine at lowest price in US market

Weekly trading ideas by Religare Broking: Buy Grasim Industries, Biocon
Biocon chairperson Kiran Mazumdar-Shaw tests positive for Covid-19
Stock calls by Sameet Chavan of Angel Broking: Sell Tata Motors, Biocon
Tata Capital to pick minority stake in Biocon Biologics for $30 million
Itolizumab to be a blockbuster opportunity for Biocon: Kiran Mazumdar-Shaw
MARKET WRAP: Sensex trims losses, ends 12 pts down; Nifty closes at 11,194
Market Ahead, July 24: All you need to know before the opening bell
Biocon Q1 pre-tax profit declines 21% to Rs 252.30 crore, revenue up 14%
Sensex ends 269 pts up, Nifty tops 11,200; RIL m-cap crosses Rs 13.5 trn
Cheer in Covid times